145 related articles for article (PubMed ID: 26604037)
1. A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.
Li Y; Kanellakis P; Hosseini H; Cao A; Deswaerte V; Tipping P; Toh BH; Bobik A; Kyaw T
Cardiovasc Res; 2016 Feb; 109(2):305-17. PubMed ID: 26604037
[TBL] [Abstract][Full Text] [Related]
2. Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis.
Kritikou E; van Duijn J; Nahon JE; van der Heijden T; Bouwman M; Groeneveldt C; Schaftenaar FH; Kröner MJ; Kuiper J; van Puijvelde GHM; Bot I
Atherosclerosis; 2019 Jan; 280():132-139. PubMed ID: 30513408
[TBL] [Abstract][Full Text] [Related]
3. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
[TBL] [Abstract][Full Text] [Related]
4. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.
Li Y; To K; Kanellakis P; Hosseini H; Deswaerte V; Tipping P; Smyth MJ; Toh BH; Bobik A; Kyaw T
Circ Res; 2015 Jan; 116(2):245-54. PubMed ID: 25398236
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
[TBL] [Abstract][Full Text] [Related]
6. Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.
Andoh Y; Ogura H; Satoh M; Shimano K; Okuno H; Fujii S; Ishimori N; Eshima K; Tamauchi H; Otani T; Nakai Y; Van Kaer L; Tsutsui H; Onoé K; Iwabuchi K
Immunobiology; 2013 Apr; 218(4):561-9. PubMed ID: 22954709
[TBL] [Abstract][Full Text] [Related]
7. Ox-LDL-induced CD80
Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
[TBL] [Abstract][Full Text] [Related]
8. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
9. Linking CD11b (+) Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis.
Rombouts M; Ammi R; Van Brussel I; Roth L; De Winter BY; Vercauteren SR; Hendriks JM; Lauwers P; Van Schil PE; De Meyer GR; Fransen E; Cools N; Schrijvers DM
Mediators Inflamm; 2016; 2016():6467375. PubMed ID: 27051078
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
[TBL] [Abstract][Full Text] [Related]
11. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice.
VanderLaan PA; Reardon CA; Cabana VG; Wang CR; Getz GS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540125
[TBL] [Abstract][Full Text] [Related]
12. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity.
Lombardi V; Stock P; Singh AK; Kerzerho J; Yang W; Sullivan BA; Li X; Shiratsuchi T; Hnatiuk NE; Howell AR; Yu KO; Porcelli SA; Tsuji M; Kronenberg M; Wilson SB; Akbari O
J Immunol; 2010 Feb; 184(4):2107-15. PubMed ID: 20083656
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J
Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
[TBL] [Abstract][Full Text] [Related]
15. NKT cells in cardiovascular diseases.
van Puijvelde GHM; Kuiper J
Eur J Pharmacol; 2017 Dec; 816():47-57. PubMed ID: 28363745
[TBL] [Abstract][Full Text] [Related]
16. Effect of natural killer T cell activation on the initiation of atherosclerosis.
van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J
Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872
[TBL] [Abstract][Full Text] [Related]
17. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
19. Natural killer T cells in atherosclerosis.
Getz GS; Reardon CA
Nat Rev Cardiol; 2017 May; 14(5):304-314. PubMed ID: 28127028
[TBL] [Abstract][Full Text] [Related]
20. Natural killer T cells in lipoprotein metabolism and atherosclerosis.
Getz GS; Vanderlaan PA; Reardon CA
Thromb Haemost; 2011 Nov; 106(5):814-9. PubMed ID: 21946866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
